# Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Page: https://stenobird.com/podcast/breast-cancer-update-757579/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances
Text version: https://stenobird.com/podcast/breast-cancer-update-757579/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md
Podcast: [Breast Cancer Update](https://stenobird.com/podcast/breast-cancer-update-757579)
Published: 2026-04-30T13:00:00+00:00
Episode link: https://breast-oncology.captivate.fm/episode/5924-yir2025-oralserdsbreast
Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/a21f43c9-7b04-4a56-a983-9f80af1177ed.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances
Duration seconds: 3438

## Resource

Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the use of oral SERDs in the management of breast cancer. CME information and select publications here .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/breast-cancer-update-757579/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.